Company Filing History:
Years Active: 2021
Title: David Clifford Sullivan: Innovator in Inflammatory Disease Treatment
Introduction
David Clifford Sullivan is a notable inventor based in Fremont, CA (US). He has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. His innovative work has led to the development of novel therapeutic approaches that hold promise for patients suffering from various disorders.
Latest Patents
David Sullivan holds a patent for "Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases." This invention provides novel peptide inhibitors of the interleukin-23 receptor, along with related compositions and methods for using these inhibitors to treat or prevent a variety of diseases and disorders, including inflammatory bowel diseases. His work in this area represents a significant advancement in therapeutic options for patients.
Career Highlights
Sullivan is currently associated with Protagonist Therapeutics, Inc., where he continues to focus on innovative solutions for treating inflammatory conditions. His expertise and dedication to research have positioned him as a key figure in the development of new medical therapies.
Collaborations
Throughout his career, David has collaborated with talented professionals, including Ashok Bhandari and Brian Troy Frederick. These collaborations have enhanced the research and development efforts at Protagonist Therapeutics, Inc., leading to impactful advancements in the field.
Conclusion
David Clifford Sullivan's contributions to the medical field through his innovative patents and collaborations highlight his commitment to improving treatment options for inflammatory diseases. His work continues to inspire advancements in therapeutic research and development.